# Spironolactone

NDC: 0378-2146
Generic name: spironolactone
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 19810203

FDA application: ANDA040424

## Active ingredients

- SPIRONOLACTONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-2146"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-2146
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=beaf74db-4159-3b59-ef99-575c3ac99aa1